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“INFLAMMATION IN ITSELF IS NOT TO BE CONSIDERED AS A DISEASE,  
BUT AS A SALUTARY OPERATION  
CONSEQUENT EITHER TO SOME VIOLENCE OR DISEASE” 
 
 – John Hunter, A Treatise of the Blood, Inflammation, and Gunshot Wounds, 1794. 
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ABSTRACT 
 
The inflammatory process is fundamental in host defense against tissue injury or 
infection. However, the inflammatory reaction may itself cause harm to the host and 
contribute to tissue damage and organ dysfunction. Leukocyte recruitment and edema 
formation are key components of the inflammatory response. This thesis reports 
experiments that were undertaken to further elucidate the mechanisms controlling 
leukocyte extravasation and concurrent alteration of vascular permeability in acute 
inflammation.  
In order for leukocytes to penetrate the vessel wall they need to sequentially interact 
with the endothelial lining and the perivascular basement membrane (BM) of which 
laminin-411 is a major constituent. The role of BM laminin-411 in leukocyte 
recruitment to inflammatory loci was addressed using α4 chain deficient (Lam4-/-) 
and wild-type (WT) mice. Recruitment of all major leukocyte subsets (neutrophils, 
monocytes, and lymphocytes) was reduced in Lam4-/- mice compared to WT. With 
the use of intravital microscopy it was concluded that this decrease was due to 
impaired diapedesis through the vessel wall.  
Concurrent with neutrophil recruitment to extravascular tissue, there is an increase in 
vascular permeability. However, the mechanism behind this alteration is unknown. It 
was shown that stimulation of neutrophils with the potent chemoattractant leukotriene 
B4 (LTB4) leads to degranulation and release of, amongst others, heparin binding 
protein (HBP). Further, postsecretory supernatants from LTB4-stimulated neutrophils 
induced intracellular calcium mobilization in endothelial cells in vitro and increase in 
vascular permeability in vivo. Selective removal of HBP from the supernatant 
significantly reduced these activities indicating a role for HBP in LTB4-induced 
plasma extravasation. The mechanism behind neutrophil-induced alteration of 
endothelial barrier function was further investigated and revealed a pivotal role of the 
kallikrein-kinin system. Neutrophil activation was shown to enable proteolytic 
processing of high molecular weight kininogen bound to endothelial cells. 
Accordingly, plasma exudation in vivo in response to challenge with leukocyte 
chemoattractants was largely annulled by antagonists of the kallikrein-kinin system. 
Collectively, the data provide novel insight into the regulation of neutrophil-induced 
plasma extravasation and may help to identify better therapeutic strategies for 
interventions in inflammatory disease.  
To investigate the role of neutrophil-induced alterations in vascular permeability in a 
clinically relevant setting, experiments were performed using controlled cortical 
impact (CCI) as a model for traumatic brain injury (TBI) in normal mice and in mice 
that were depleted of neutrophils. Neutrophil depletion did not significantly affect 
plasma leakage across the blood-brain barrier after CCI. Yet, neutrophils were found 
to play a role in edema formation in brain tissue after injury. At a later phase, 
neutropenic mice displayed a decreased number of activated microglia, and an 
attenuation of tissue loss after injury. These results suggest that neutrophils contribute 
to the secondary injury following TBI. Altogether, this thesis provides insight into the 
role of the BM in leukocyte recruitment and clarifies the mechanism behind 
neutrophil-induced edema formation in acute inflammation. 
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INTRODUCTION 
 
INFLAMMATION 
Inflammation is the body’s protective response to foreign and noxious stimuli and 
which serves to eliminate the initial cause of cell injury as well as the necrotic cells 
resulting from the original insult. The inflammatory response also has a role in 
healing and reconstitution of tissue. It involves the coordinated response of blood 
vessels, leukocytes and plasma components. Vascular and cellular changes are 
triggered by soluble factors that are produced by various cells or derived from plasma 
proteins as a response to the inflammatory stimulus. Inflammation usually terminates 
when the initiating stimulus disappear. However, sometimes inflammation may be 
inappropriately triggered or not adequately controlled and may then cause harm to the 
host. Examples of these conditions include chronic inflammatory diseases such as 
rheumatoid arthritis, atherosclerosis and fibrosis of the lung as well as acute 
conditions such as sepsis (Kumar & Robbins, 2009). 
The inflammatory response involves several components: 
• Circulating cells such as polymorphonuclear leukocytes (neutrophils, 
eosinophils and basophils), lymphocytes, monocytes and platelets, and plasma 
proteins including clotting factors, kininogens and complement components. 
• The vascular wall consisting of the endothelium, basement membrane, 
pericytes and smooth muscle cells. 
• The extracellular matrix hosting mast cells, macrophages and dendritic cells 
(Kumar et al., 2003).  
 
Microcirculatory Changes in Inflammation 
The four cardinal signs of inflammation were listed by Celcius around 100 AD and 
are rubor (redness), tumor (swelling), calor (heat) and dolor (pain). Rudolf Virchow 
added the fifth sign; loss of function (functio laesa) in the 19th century. These signs 
occur as a result of adaptive changes in the microcirculation, namely heat and redness 
due to arteriolar dilatation and increased local blood flow, and swelling of the tissue 
due to increased vascular permeability and consequent plasma leakage from 
postcapillary venules.  
 
Acute and chronic inflammation 
The inflammatory response can be divided into an acute and a chronic pattern. 
However, these forms of inflammation frequently overlap. Acute inflammation is of 
short duration (minutes to days) and is characterized by accumulation mainly of 
neutrophilic granulocytes (see later section) and concurrent exudation of fluid and 
plasma proteins. Blood flow to the affected area is increased by upstream vasodilation. 
The endothelium is affected to decrease its barrier function, which leads to an efflux 
of plasma resulting in edema formation. Neutrophils emigrate from the 
microvasculature to the area of injury or infection (Kumar et al., 2003). Acute 
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inflammation can be triggered by several factors; infections and microbial toxins, 
physical and chemical injury, tissue damage resulting from ischemia or trauma, and 
immunological reactions.  
Chronic inflammation is of longer duration (days to years) and involves primarily 
mononuclear leukocytes (monocytes and lymphocytes) and macrophages with 
associated vascular proliferation and scarring. A chronic inflammatory condition is 
prolonged and has simultaneously occurring active inflammation, tissue destruction 
largely directed by inflammatory cells, and repair which involves angiogenesis and 
fibrosis. Acute inflammation can progress to chronic if the injurious agent is 
persistent or if the normal healing process is disturbed. Examples of chronic 
conditions include persistent microbial infections or autoimmune disorders such as 
rheumatoid arthritis or multiple sclerosis (Kumar et al., 2003). This thesis focuses on 
the vascular changes and cellular events during acute inflammation.  
 
Cells of the immune system 
Immune cells are classified either as bloodborne or tissue residing. Based on 
histological appearance, the bloodborne cells are further distinguished as either 
polymorphonuclear or mononuclear. Polymorphonuclear leukocytes (PMN) include 
neutrophilic granulocytes (neutrophils) that are recruited during acute inflammation 
to phagocytose microbes; eosinophilic granulocytes that are recruited during allergic 
inflammatory reactions and parasitic infections; and basophilic granulocytes that 
participate in allergic inflammation. Monocytes and lymphocytes make up the 
mononuclear cells. Monocytes are recruited from the blood during later stages of 
acute inflammation and during chronic inflammation, and differentiate into 
macrophages in the extravascular tissue where they act as phagocytes. Lymphocytes 
are specialized cells of the adaptive immune system that act as directors of antigen-
specific immune responses including the synthesis of antibodies. Tissue residing 
immune cells include mast cells that produce lipid mediators and histamine, and 
macrophages that produce cytokines and function as effector cells in cell-mediated 
immunity (Abbas & Lichtman, 2009).  
 
The neutrophil 
Neutrophils constitute the predominant cell type early in the inflammatory reaction as 
they are more numerous in the blood than monocytes and react more rapidly to 
chemokines (Kumar & Robbins, 2009). They respond especially to bacterial and 
fungal infections, and die after a few hours in the tissue. With the help of reactive 
oxygen species (ROS) they phagocytose and destroy microbes. Neutrophils recognize 
antigen in the blood and extravascular tissue using several types of receptors such as 
toll like receptors, and receptors for formyl methionine peptides and products of 
complement activation (Abbas & Lichtman, 2009). The cytoplasm is filled with four 
types of granules that are formed in a specific sequence during differentiation in the 
bone marrow (Borregaard et al., 2007): 
• Primary or azurophilic granules are formed during the early stage of PMN 
differentiation and contain bactericidal and cytotoxic mediators such as 
myeloperoxidase (MPO), which catalyzes the formation of hypochloric acid 
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from hydrogen peroxide and is very toxic for microbes; defensins and 
bacterial permeability increasing protein, and the serine proteases elastase, 
cathepsin G, proteinase 3, and heparin binding protein (HBP/ azurocidin). The 
serine proteases are cationic glycoproteins of similar size. 
• Secondary or specific granules, which are created after the primary granules 
are the most common. They contain bactericidal proteins such as lactoferrin, 
LL-37 and lysozyme, as well as NAPDH-oxidase, which is involved in the 
production of ROS. 
• Tertiary or gelatinase granules contain matrix metalloproteases (MMPs) that 
degrade extracellular matrix proteins.  
• Secretory vesicles contain complement receptors and integrins (i.e. 
CD11/CD18) as well as plasma proteins. They act as storage of membrane 
proteins that can be mobilized rapidly during activation (Borregaard et al., 
2007). The inactive serine protease HBP is also found in the secretory vesicles 
(Tapper et al., 2002). 
The granules are mobilized as a response to neutrophil activation in a hierarchical 
order starting with the secretory vesicles, tertiary granules and secondary granules. 
The secretory vesicles are released during the contact between the PMN and 
endothelial cell (EC) as a result of selectin signaling or by inflammatory mediators on 
the endothelium (Borregaard et al., 2007). The release results in increased adhesion 
via β2-integrins. The tertiary granules contain MMPs which are able to degrade 
collagen IV in the basement membrane (BM) and it is likely that migration through 
the BM requires the release of these granules (Reichel et al., 2008). Primary and 
secondary granules are released when the neutrophil has emigrated to the 
extravascular tissue and contribute to the reactive oxygen-dependent and -independent 
bactericidal activity. The degree to which the granules are released is determined by 
the strength of the inflammatory stimulus. A strong stimulus will lead to high enough 
intracellular Ca2+ concentrations ([Ca2+]i) to induce the release of primary granules 
(Lacy & Eitzen, 2008).  
The degranulation process can occur extracellularly or intracellularly and is initiated 
upon receptor-mediated stimulation of PMN. The release of granules is dependent on 
Ca2+ and to a certain extent hydrolysis of ATP (Theander et al., 2002). ATP acts as an 
energy source for SNARE complex reorganization and Ca2+ is required for 
cytoskeletal activation. Actin is found to associate with all granule subsets, which 
indicates its importance in the control of degranulation (Jog et al., 2007). Neutrophils 
express three Src family members that, when activated by receptor ligation, control 
granule release (Mocsai et al., 2000). Finally, the Rho subfamily of GTPases, which 
regulates actin cytoskeletal rearrangement, is also involved in neutrophil exocytosis 
(Lacy & Eitzen, 2008).  
 
Inflammatory mediators 
The major cell types that produce substances mediating the acute inflammatory 
reaction are platelets, neutrophils, monocytes/macrophages and mast cells. 
Inflammatory mediators are also derived from plasma proteins, e.g. kinins and 
complement factors, and are produced mainly in the liver (Kumar & Robbins, 2009). 
There are several mediators that act directly on the endothelial cells to increase 
vascular permeability; these will be discussed a later section.  
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Chemoattractants 
Chemoattractants are soluble molecules that can diffuse away from their site of 
production and are able to stimulate directional movement of leukocytes (Figure 1A). 
Endogenous chemoattractants include cytokines, in particular chemokines, 
components of the complement system and arachidonic acid metabolites. Foreign 
substances can act as exogenous chemoattractants and the most common are bacterial 
products. Leukocytes respond to chemoattractants in a process called chemotaxis in 
which cells move in the direction of increased concentration of a chemoattractant 
(Franca-Koh & Devreotes, 2004). Examples of chemoattractants that act on 
neutrophils include the formyl peptide formyl-Methionyl-Leucyl-Phenylalanine 
(fMLP), complement factor 5a (C5a), leukotriene B4 (LTB4) and platelet activating 
factor (PAF). Neutrophils express receptors (FPR and FPRL1) recognizing fMLP and 
other formyl peptides from bacteria (Fu et al., 2006). C5a is a product of complement 
system activation and binds the C5aR and C5L2 receptors on neutrophils (Monk et al., 
2007). LTB4 binds the BLT1 and BLT2 receptors on neutrophils and will be discussed 
in a later section. Platelet activating factor is a phospholipid-derived mediator, 
produced by e.g. PMN, EC and platelets, which binds to the PAF receptor on 
neutrophils (Honda et al., 2002).  
Although different chemoattractants are recognized by separate receptors, the 
receptors share similar features and belong to the pertussis toxin-sensitive subfamily 
of G protein-coupled receptors (GPCR). Receptor activation will lead to the activation 
of multiple downstream second messengers and a transient elevation in the 
intracellular Ca2+ concentration resulting in chemotaxis, mobilization of granules, and 
generation of reactive oxygen species (Fu et al., 2006). Neutrophil exposure to 
chemoattractants is enhanced during rolling on the endothelium since the contact 
between the leukocyte and vessel wall is prolonged. The chemoattractants have 
limited effect in the circulation because they would be rapidly diluted and swept away 
by blood flow (Springer, 1994).  
 
Cytokines and chemokines 
Cytokines are secreted in small amounts in response to external stimuli and bind to 
high affinity receptors on target cells. Most act in an autocrine or paracrine fashion 
and generally affect the endothelium to induce adhesion molecule expression and also 
cause secretion of other cytokines (Figure 1A). The effects are often systemic (Kumar 
& Robbins, 2009). During systemic infections the amounts produced may be large 
enough to act in an endocrine manner. Interleukin (IL)-1 and tumor necrosis factor 
(TNF) are produced by macrophages, EC and some epithelial cells. They cause 
activation of endothelial cells and leukocytes, act on the hypothalamus to induce fever, 
and stimulate the liver to synthesize acute phase proteins (Abbas & Lichtman, 2009). 
Chemokines are a family of chemoattractant cytokines and include CXC- or α-
chemokines (e.g. IL-8) that act on neutrophils and non-hematopoetic cells, and CC- or 
β-chemokines that affect mononuclear cells (e.g. monocyte chemotactic protein-1, 
MCP-1, which acts on monocytes) (Charo & Ransohoff, 2006). Chemokines may be 
displayed to the leukocyte at high concentrations as they can attach to proteoglycans 
on EC and in the extracellular matrix (Kumar & Robbins, 2009). IL-8 is produced by 
T lymphocytes, epithelial cells, keratinocytes, fibroblasts, endothelial cells and 
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neutrophils (Witko-Sarsat et al., 2000). It binds to two receptors (CXCR1 and 
CXCR2) that are abundant on neutrophils and plays a role in many of the neutrophil 
antimicrobial functions such as chemotaxis, degranulation and oxidative burst (Stillie 
et al., 2009). 
 
LEUKOCYTE RECRUITMENT 
The recruitment of leukocytes is a key component in inflammatory reactions. 
Leukocytes are activated at sites of injury or infection and extravasate to the 
surrounding tissue in a coordinated multistep process that involves rolling along the 
endothelium, firm adhesion and subsequent migration through the vessel wall (Muller, 
2002) (Figure 1A). Recently, additional steps were added to the three step cascade to 
include slow rolling, adhesion strengthening, intraluminal crawling, paracellular and 
transcellular migration, and migration though the basement membrane (Ley et al., 
2007).  
Figure 1. Schematic figure of leukocyte recruitment and plasma extravasation. A) The leukocyte recruitment cascade with
key molecules in each step indicated. Cytokines and chemoattractants activate (red arrows) endothelial cells and leukocytes
respectively. B) Neutrophil granule release as a consequence of β2 integrin ligation and chemoattractant activation (red arrows)
during adhesion to the endothelial cell. C) Regulation of vascular permeability by directly acting mediators and possible factors
involved in neutrophil-mediated alteration of permeability. Adherens and tight junction proteins, represented in green, associate
with the actin cytoskeleton. 
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Intravascular adhesion 
Leukocyte rolling along the endothelium is mediated primarily by the selectins (Ley 
et al., 2007). L-selectin is constitutively expressed on circulating neutrophils, 
monocytes and most lymphocytes. P-selectin is stored in the α-granules of platelets 
and Weibel-Palade bodies in EC and appears on the surface within minutes after 
stimulation as these granules fuse with the plasma membrane. The expression of E-
selectin is limited to endothelial cells (Kansas, 1996). The dominating ligand for all 
three selectins is PSGL1 (Ley et al., 2007). The interaction between the selectins and 
their ligands is very loose and the shear stress from the blood causes the leukocyte to 
detach from the endothelium and bind to another ligand in a repetitive cycle, thus 
causing the leukocyte to roll along the endothelium. Rolling allows the leukocyte to 
establish a more stable adhesion to the endothelial surface via integrins (Muller, 2002).  
The arrest of leukocytes on the endothelium is rapidly triggered by chemokines or 
other chemoattractants and is mediated by the ligation between integrins on the 
leukocytes and immunoglobulin superfamily members such as intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on the 
endothelial cells. Cytokines released during inflammation stimulate the EC to express 
adhesion molecules and synthesize chemokines and lipid chemoattractants that are 
exposed on the luminal surface of the EC. Chemoattractants are also transported from 
the abluminal surface and can be generated by proteolytic cleavage in activated 
macrophages and platelets (Ley et al., 2007). For example, EC produce IL-8 and store 
it in Weibel-Palade bodies so that it can be rapidly presented on the EC surface 
(Witko-Sarsat et al., 2000). Many chemokines bind to glycosaminoglycans on the EC 
surface and this exposure is necessary for leukocyte recruitment (Johnson et al., 2005). 
Integrins are heterodimeric receptors that consist of a paired α and β chain and are 
classified according to the common β chain. There are three major integrin 
subfamilies among leukocytes; β1 (CD29), β2 (CD18), and β3 (CD61) (Springer, 
1994). When leukocytes are stimulated with chemoattractants and chemokines there is 
a rapid GPCR-signaling which leads to a conformational change of the integrin from a 
low-affinity to a high-affinity conformation leading to opening of the ligand-binding 
pocket (Laudanna et al., 2002). In addition to mediating adhesion, integrins generate 
intracellular signals to regulate functions such as cell motility, proliferation and 
apoptosis (Ley et al., 2007). 
The β2-integrin CD11/CD18 is expressed exclusively on leukocytes and mediates firm 
adhesion to vascular endothelium, which is necessary for leukocyte recruitment to 
extravascular tissue (Arfors et al., 1987). The predominant receptor on the 
endothelium responsible for CD11/CD18 binding is ICAM-1 (Muller, 2002). There 
are two types of β2-integrins that bind to ICAM-1; αLβ2 (CD11a/CD18, LFA-1), 
which is expressed on B and T lymphocytes, monocytes and neutrophils and αMβ2 
(CD11b/CD18, Mac1), which is expressed on monocytes and neutrophils only 
(Issekutz & Issekutz, 1992). ICAM-1 appearance on the endothelial cells is increased 
following stimulation with inflammatory mediators. This induction is largely 
regulated at the mRNA level and increased surface expression is seen after 4 hours 
and peaks after 24 hours (Springer, 1990).  
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Extravasation 
Migration through the vessel wall occurs through three barriers: the endothelial cell, 
the basement membrane and the pericyte sheath which surrounds the vessel. 
Penetration through the basement membrane takes longer than through the 
endothelium. Several factors such as chemoattractans, shear flow, and interaction with 
ICAM-1 and VCAM-1 may stimulate transendothelial migration (Ley et al., 2007). 
Following adhesion, which is CD11a/CD18 dependent, neutrophils migrate on the 
endothelial cells to find preferential sites for transmigration in a process called 
intraluminal crawling and which is mediated by CD11b/CD18 (Phillipson et al., 
2006). This process is stimulated by chemoattractants that bind to proteoglycans, e.g. 
heparan sulfate, on the endothelial cells. Without a chemotactic stimulus which is held 
in place by proteoglycans, intraluminal crawling, and by extension leukocyte 
recruitment, is decreased (Massena et al., 2010).  
The mechanism of transendothelial migration is not yet completely understood. The 
prevailing idea is that transmigration is a paracellular process, i.e. the leukocyte 
migrates through the endothelium by squeezing between adjacent endothelial cells. 
However, transcellular migration has been suggested as an alternative path through 
the endothelial lining based on observations in both in vivo (Feng et al., 1998; Hoshi 
& Ushiki, 1999) and in vitro models (Carman & Springer, 2004). For example, there 
is in vitro evidence for the formation of “transmigratory cups” rich in ICAM-1, 
VCAM-1, cytoplasmic proteins and cytoskeletal components that allow leukocytes to 
migrate through the endothelial cell (Carman & Springer, 2004). However, 
supposedly this route is only taken by a small percentage of transmigrating cells and it 
uses similar junctional molecules as during paracellular migration (Ley et al., 2007). 
 
Paracellular migration 
Inflamed endothelial cells can redistribute junctional molecules in a fashion that 
favors transendothelial migration of leukocytes. Several molecules have been 
identified as key players in paracellular transmigration. Platelet/endothelial cell 
adhesion molecule-1 (PECAM-1), junctional adhesion molecule (JAM), vascular 
endothelial cadherin (VE-cadherin) and CD99 have received the most attention. These 
molecules are localized to the junctions between endothelial cells. They have been 
investigated both in vivo and in vitro and have been found to be of different 
importance in response to varying stimuli and depending on leukocyte subtype.  
PECAM-1 is a transmembrane protein, which is expressed by plateles, most subsets 
of leukocytes, and by endothelial cells. It is concentrated at interendothelial junctions 
and supports cell-cell adhesion through homotypic interaction (Thompson et al., 
2001). Inhibiting the function of this molecule attenuates transendothelial migration in 
vitro (Schenkel et al., 2002) and in vivo (Wakelin et al., 1996; Duncan et al., 1999; 
Thompson et al., 2001). VE-cadherin conjoins adjacent EC through homotypic 
interaction and is linked to the cytoskeleton and signaling components inside the cell. 
Distribution of a VE-cadherin antibody in vivo enhances neutrophil emigration 
(Gotsch et al., 1997) indicating that it acts to prevent the passage of leukocytes. In 
addition, phosphorylation of VE-cadherin, which weakens its adhesive properties, is 
required for leukocyte transendothelial migration in vitro (Allingham et al., 2007; 
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Alcaide et al., 2008), and transmigration triggers the formation of gaps in VE-
cadherin (Alcaide et al., 2008). 
As these EC molecules signal to each other through the endothelial cell, it is 
important that there is a sequential interaction between them and leukocyte (Ley et al., 
2007). For example, inhibition of CD99 blocks leukocyte migration distal to PECAM-
1 and blockade of both molecules have an additive effect (Schenkel et al., 2002; Lou 
et al., 2007). There is also evidence that PECAM-1 and JAM-A act sequentially as 
there is no additive effect of dual blockade (Woodfin et al., 2007). The JAM family is 
composed of JAM-A to C (the classical members) and the non-classical members 
endothelial cell selective adhesion molecule (ESAM), coxsackievirus and adenovirus 
receptor, JAM-4 and JAM-L (Bazzoni, 2003), and has been implicated in the 
regulation of leukocyte transmigration (Garrido-Urbani et al., 2008). 
 
Migration through the perivascular membrane 
Following transendothelial migration, the leukocyte needs to penetrate the 
perivascular basement membrane (Nourshargh & Marelli-Berg, 2005). The BM is a 
50-100 nm thick sheet-like structure that is found basolaterally to the endothelium. It 
provides structural support and consists of large insoluble molecules that self-
assemble via specific binding sites (Kalluri, 2003). The perivascular BM consists of 
pericytes and extracellular matrix proteins such as laminin-411 and -511 (laminin-8 
and -10), collagen type IV, nidogen, entactin and heparan sulphate proteoglycans. The 
laminins are large heterotrimers consisting of α, β and γ polypeptide chains 
(Colognato & Yurchenco, 2000). The α4 chain-containing laminin-411 (α4:β1:γ1) is 
widely expressed in vascular endothelial BM (Iivanainen et al., 1997) and has a 
significant role in normal blood vessel maturation (Thyboll et al., 2002). Literature 
covering the field of leukocyte migration through the basement membrane is sparse 
partly due to difficulties of constructing physiologically relevant in vitro models of 
the basement membrane and associated pericytes. The BM is thought to provide a 
greater resistance to migration than does the endothelial cell, and there is no 
consensus as to how the cells migrate through this barrier. Hence, the following 
mechanisms have been suggested:  
1. Migration through regions with low expression of basement membrane 
proteins. Leukocytes have been found to migrate through gaps between 
pericytes (Wang et al., 2006; Voisin et al., 2010). Pericytes also regulate the 
presence of low expression sites that are permissive for leukocyte 
transmigration. These permissive sites are low in collagen IV and laminin-511 
and are present in many tissues. The low expression regions are though to act 
as gates for migrating monocytes and neutrophils (Nourshargh et al., 2010). 
2. Basement membrane remodeling during transmigration. As PMN migrate 
through the low expression regions, these regions experience a transient 
enlargement. The mechanism behind this remodeling is unclear, but evidence 
exists that neutrophils that have migrated through the BM have laminin 
fragments on the cell surface indicating possible proteolytic breakdown of 
laminin (Wang et al., 2006). However, the role for proteases in leukocyte 
recruitment is inconclusive. There is some support for a role of MMPs 
(Reichel et al., 2008) and elastase (Young et al., 2004; Wang et al., 2006). On 
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the other hand, it has been shown that elastase deficiency does not affect 
leukocyte recruitment to extravascular tissue (Hirche et al., 2004; Wang et al., 
2006). 
3. Biochemically or biophysically permissive sites. The composition of the BM 
could affect leukocyte transmigration. The laminin α4 chain, but not the α5 
chain, is truncated which could lead to reduced cross-linking to collagen IV 
creating a less dense mesh-work of matrix proteins (Hallmann et al., 2005). 
This in turn might facilitate migration through the BM. However, there is not 
yet evidence for this hypothesis. 
Following migration through the BM, the leukocyte continues to migrate towards the 
site of injury or infection through the three-dimensional network of extracellular 
matrix proteins. The β1-integrin subfamily includes receptors that bind cells to 
extracellular matrix components such as fibronectin, laminin and collagen (Springer, 
1990; Muller, 2002). Members of the β1-integrin family are up-regulated as the 
leukocyte undergoes diapedesis (Werr et al., 1998), and this integrin family has been 
shown to be primarily responsible for regulating leukocyte migration in the 
extravascular tissue (Werr et al., 1998; Werr et al., 2000).  
 
PERMEABILITY INCREASES AND EDEMA FORMATION DURING ACUTE 
INFLAMMATION 
The microvascular changes that occur during acute inflammation are designed to 
maximize the movement of plasma proteins and circulating cells out of the circulation 
to the site of injury or infection. Following a transient vasoconstriction, there is a 
dilation of arterioles leading to an increase in blood flow locally as reflected by the 
heat and redness of the tissue. Several mediators such as prostaglandins, histamine 
and nitric oxide (NO) acting on smooth muscle cells contribute to the increase in 
blood flow. The vasodilation is followed by an increased microvascular permeability, 
leading to leakage of plasma from the vasculature (Kumar & Robbins, 2009) (Figure 
1C). A controlled increase in vascular permeability aids in clearing the inflammatory 
stimulus as the exudate contains complement proteins and antibodies. However, in 
cases such as influenza-induced pneumonia, burns or brain injury, edema can lead to 
hospitalization or death (DiStasi & Ley, 2009).  
 
The endothelial barrier and physiologic regulation of vascular 
permeability 
The barrier between the blood and extravascular tissue consists of the endothelium 
with its glycocalyx and the underlying basement membrane. The resting endothelium 
acts as a sieve with an average pore size of 3 nm and diffusion of molecules occurs 
paracellularly (Mehta & Malik, 2006). Although the glycocalyx and basement 
membrane provide a barrier to macromolecule passage, the primary mechanism 
behind increased vascular permeability and edema formation in inflammation is 
endothelial cell contraction leading to paracellular gaps through which plasma 
macromolecules can pass (Mehta & Malik, 2006).  
Fluid exchange across the endothelium is governed by the Starling principle, which 
states that the net filtration rate depends on the hydrostatic and colloidosmotic 
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pressures in the intravascular and extravascular compartments. The permeability of 
the endothelium will also affect the net filtration rate (Boron & Boulpaep, 2005). 
Inflammatory edema results from an increase in colloid-osmotic pressure in the 
interstitium as this will draw fluid from the intravascular compartment (Lindbom, 
2003). An increase in hydrostatic pressure will augment this effect and the 
permeability increasing ability of inflammatory mediators such as bradykinin and 
histamine is enhanced by e.g. prostaglandin E2 (PGE2) which acts as a vasodilating 
agent thus increasing the blood flow to the inflamed tissue (Williams, 1983).  
The passage of plasma proteins, solutes and fluid across the barrier created by the 
endothelium can take two routes – transcellular (via transcytosis) or paracellular 
(through interendothelial junctions), and endothelial barrier function is most likely 
regulated by a crosstalk between interendothelial junctions and transcytosis. 
Transcellular passage occurs primarily through vesicular transport. This mechanism is 
initiated by fission of caveolin-1 rich domains of plasma membrane, caveolae, on the 
luminal side of the EC. The caveolar vesicles are then transported to the basal surface 
where they fuse with the plasma membrane and release macromolecules by 
exocytosis (Komarova & Malik, 2010). The permeability increase during 
inflammation is however most likely through the paracellular route.  
Paracellular permeability is regulated by the interplay of adhesive forces between the 
endothelial cells and the counteradhesive forces generated by endothelial actomyosin 
contraction (Mehta & Malik, 2006). Endothelial cells are held together by adherens 
junctions (AJ) and tight junctions (TJ) that have comparable functions although they 
are formed by different molecules. Similar between the two is that adhesion is 
mediated by transmembrane proteins that promote homophilic interaction between 
adjacent cells. AJs are made up of a complex consisting of VE-cadherin, catenins and 
plakoglobin (Dejana, 2004). Five cadherin like repeats make up VE-cadherin that 
associates with VE-cadherin on adjacent EC in a Ca2+ dependent manner. 
Intracellularly, VE-cadherin binds p120-catenin (p120), and α- and β-catenins, which 
link VE-cadherin to the cytoskeleton (Vandenbroucke et al., 2008). The interactions 
between cadherins, kinases and the Rho GTPases are regulated by p120 which 
controls the phosphorylation and stability of cadherin-cadherin and cadherin-catenin 
interaction (Mehta & Malik, 2006). Tyrosine phosporylation of VE-cadherin and 
other components of AJs are associated with weak junctions and impaired barrier 
function (Dejana et al., 2008), and an antibody against VE-cadherin results in 
increased vascular permeability in vivo (Corada et al., 1999). Vascular endothelial 
protein tyrosine phosphatase (VE-PTP) supports VE-cadherin function and is required 
for maintaining EC barrier function (Nottebaum et al., 2008). Tight junctions mediate 
adhesion between cells by members of the claudin family, occludin, JAMs A-C and 
ESAM (Dejana, 2004). The composition of TJs and AJs differ depending on the 
vascular bed. AJs, consisting of VE-cadherin mediated adhesion, are thought to 
maintain structural integrity of the junctions whereas TJs are secondary and appear 
mainly in larger blood vessels and as part of the blood-brain barrier (BBB, see later 
section) (Komarova & Malik, 2010). 
Contraction of vascular EC is regulated by actin-myosin interaction. This interaction 
is mainly controlled by phosphorylation of myosin light chain (MLC), which can be 
altered by three different mechanisms: 1) direct phosphorylation by myosin light 
chain kinase (MLCK); 2) dephosphorylation of MLC by myosin light chain 
phosphatase (MLCP), and 3) inhibition of MLCP by RhoA through its downstream 
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effector Rho kinase (ROCK) thus potentiating MLC phosphorylation (Vandenbroucke 
et al., 2008). MLC phosphorylation is indicated in EC contraction by several 
mediators such as bradykinin, histamine, thrombin and in response to neutrophil 
activation, and inhibition of MLCK attenuates increases in vascular permeability 
(Yuan, 2002). Phosphorylation of MLC is Ca2+ dependent and the disruption of AJs 
through microtubule destabilization, which results in EC contraction occurs in a 
RhoA/ROCK dependent manner (Vandenbroucke et al., 2008).  
The family of small Rho GTPases, including RhoA, Cdc42 and Rac1, are key 
regulators of actin reorganization and signaling in endothelial cells (Strey et al., 2002). 
It has been shown that Rac1 and Cdc42 signaling is important in stabilizing the 
endothelial barrier (Wojciak-Stothard et al., 2005). RhoA and ROCK, on the other 
hand, have been assigned an excitatory role in hyperpermeability caused by histamine 
or PMN activation (Wojciak-Stothard et al., 2001; Breslin & Yuan, 2004). Rac1 acts 
upstream of RhoA and prevents endothelial cell contraction. When Rac1 is inhibited, 
as during endothelial cell hypoxia, RhoA is activated leading to stress fiber formation 
(Wojciak-Stothard et al., 2005).  
The endothelium is the major barrier to macromolecules. However, the glycocalyx on 
endothelial cells and the basement membrane also contribute to the barrier function. 
The glycocalyx, which is a negatively charged surface coat of proteoglycans, 
glycosaminoglycans and plasma proteins lining the luminal side of the endothelium, 
may limit the passage of macromolecules, especially charge-selectively, to the 
endothelial cell surface (Mehta & Malik, 2006). The glycocalyx shields the vascular 
wall from direct exposure of blood flow by its positioning at the interface between the 
blood and the endothelium. It has been implicated in the maintenance of endothelial 
permeability and it is suggested that the protein concentration gradient which is 
necessary for colloid osmotic pressure is localized across the glycocalyx (van den 
Berg et al., 2006). Degradation of endothelial glycocalyx in the myocardium leads to 
edema formation (van den Berg et al., 2003). The basement membrane could add to 
the barrier function of the endothelium by interaction between its components and 
integrins on the endothelial cell leading to enhanced cell-cell adhesion (Mehta & 
Malik, 2006). 
Sphingosine 1-phosphate has been shown to enhance EC barrier function both in vivo 
and in vitro. It is released from erythrocytes and platelets and binds to receptors on the 
endothelium where it causes increased VE-cadherin and β-catenin expression 
resulting in enhanced barrier function (Wang & Dudek, 2009). Other molecules that 
are able to enhance barrier function are activated protein C and adenosine, which can 
do so through several mechanisms (DiStasi & Ley, 2009). 
 
Directly acting mediators of increased vascular permeability 
Many soluble factors of different origin such as thrombin, bradykinin, histamine, 
cysteinyl leukotrienes, oxygen free radicals, and vascular endothelial growth factor 
(VEGF) are known to induce increased vascular permeability through direct action on 
the endothelial cells (Mehta & Malik, 2006; Vandenbroucke et al., 2008) (Figure 1C).  
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Leukotrienes and prostaglandins 
Prostaglandins and leukotrienes (LT) are arachidonic acid derivatives that have long 
been known to mediate inflammatory responses such as vasodilation, increased 
vascular permeability and neutrophil recruitment. Prostaglandins can be formed by 
most cells and LT are predominantly made by inflammatory cells such as PMN, 
macrophages and mast cells (Funk, 2001). 5-LO is the key enzyme in the cascade, 
which transforms arachidonic acid to LTA4. LTA4 can be hydrolyzed yielding LTB4, 
or conjoined with glutathione to form LTC4. LTC4 can in turn be metabolized 
extracellularly yielding LTD4 and LTE4. A collective name for LTC4, LTD4 and LTE4 
is the cysteinyl leukotrienes and they are known for their slow and sustained smooth 
muscle contracting abilities. LTB4 is a potent neutrophil chemoattractant thus 
stimulating neutrophil recruitment (Funk, 2001). Leukotrienes act at GPCRs. 
Leukocytes express the BLT1 and BLT2 receptors which bind LTB4 with high and low 
affinity, respectively. These receptors cause neutrophil activation leading to 
chemotaxis and degranulation (Tager & Luster, 2003). The cysteinyl leukotrienes 
bind to the Cys-LT1 and Cys-LT2 receptors that are present on airway smooth muscle 
cells and vascular endothelial cells (Funk, 2001), and are known as potent inducers of 
increased vascular permeability (Dahlen et al., 1981). 
 
Histamine 
Histamine is stored preformed in mast cell granules and can therefore be released 
quickly. Mast cells are localized in the connective tissue adjacent to blood vessels and 
release histamine as a response to several stimuli such as allergic reactions, 
anaphylatoxins, substance P and cytokines (Kumar & Robbins, 2009). The 
permeability increasing effect of histamine results from activation of the H1 receptor 
on endothelial cells (Repka-Ramirez & Baraniuk, 2002). Histamine also acts as a 
vasodilator, predominantly via the H2 receptor, thus enhancing edema formation. 
 
Bradykinin 
A distinct chemical entity with established impact on vascular permeability is 
represented by the kallikrein/kinin system, known also as the contact phase system, 
with its major components high molecular weight kininogen (HK), plasma kallikrein 
(PK), and factor XII (FXII). These proteins assemble on the surface of endothelial 
cells and of PMN (Schmaier, 2008). Kinins, with bradykinin being its best 
characterized member, are low-molecular weight peptides that have the ability to 
activate endothelial cells and cause vasodilation, increased vascular permeability, 
production of NO and arachidonic acid mobilization. They are also able to stimulate 
sensory nerve endings causing pain. These effects make them an important player in 
the inflammatory process as they are able to elicit the cardinal signs of inflammation. 
Bradykinin can be generated via two general pathways: 
1. Tissue kallikrein, which is secreted by many cells in the body, digests low-
molecular weight kininogen (LK) to yield kallidin that is cleaved to form 
bradykinin. 
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2. The second mechanism for bradykinin formation involves molecules of the 
intrinsic coagulation pathway. The initiating protein in this cascade is Factor 
XII, which binds to negatively charged macromolecular surfaces and 
autoactivates to generate FXIIa. Factor XIIa acts on plasma prekallikrein 
which circulates as a complex with HK. The PK-HK complex binds to 
endothelial cells with the HK domains 3 and 5. Activation of plasma 
prekallikrein by Factor XIIa leads to the formation of kallikrein, which is able 
to cleave HK to generate bradykinin (Kaplan et al., 2002). 
Bradykinin binds to two types of receptors on the endothelial cell, B1 and B2. The B2 
receptor is constitutively expressed and the B1 receptor is induced by inflammatory 
stimuli such as TNF and IL-1. The kinin receptors are GPCRs and activate several 
second messenger systems leading to increased Ca2+ and activation of protein kinase 
C (PKC) (Howl & Payne, 2003). In vitro studies activating the kallikrein-kinin system 
have generally been performed with non-physiological negatively charged surfaces 
such as glass or kaolin, and generation of bradykinin in the contact of blood with 
these surfaces explains the alternative name “the contact system”. The physiological 
activator of the system is yet unknown (Kaplan et al., 2002).  
 
Thrombin 
Thrombin is a major product of the coagulation cascade. Proteolytic cleavage of 
prothrombin results in the formation of thrombin which binds to three different 
proteinase-activated receptors (PARs). PAR-1 is located on endothelial cells and 
activation of this receptor results in increased vascular permeability (Bogatcheva et al., 
2002).   
 
Neutrophil-induced permeability increases in acute inflammation 
It has been known for long that PMN induce increased vascular permeability. 
Wedmore and Williams showed, in 1981, that PMN are required for the permeability 
increase induced by chemoattractants such as fMLP, C5a, and LTB4 (Wedmore & 
Williams, 1981). The mechanism with which neutrophils cause edema formation is 
yet unknown, and there are several ways that PMN can stimulate alterations in 
vascular permeability; via secreted products, via adhesion, via transmigration or by 
the release of ROS (Wang & Doerschuk, 2002) (Figure 1C).  
 
Neutrophil adhesion as a mechanism for increased permeability 
It was previously thought that the PMN-associated increase in permeability were due 
to leakage of plasma during PMN transendothelial migration (Lindbom, 2003). 
However, adhesion alone can induce this phenomenon (Gautam et al., 1998; Lindbom, 
2003). That PMN do not have to migrate through the endothelium for edema 
formation to occur is supported by the rapid response in permeability alteration. When 
PMN attach there is an increase in Ca2+, MLCK activation and actin cytoskeleton 
remodeling leading to increased permeability (Huang et al., 1993). This occurs 
concurrently with signaling to the endothelial cell junctional proteins that become 
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phosphorylated and there is a downregulation of the adhesive contacts between the 
endothelial cells (Bolton et al., 1998; Tinsley et al., 1999).  
Neutrophils induce MLC phosphorylation and activation of RhoA, ROCK and fokal 
adhesion kinase which leads to stress fiber formation, and dissociation of EC 
junctional proteins resulting in gap formation (Lindbom, 2003). As the PMN adheres, 
primarily through β2-integrin binding to ICAM-1, there is a rapid and transient 
increase in endothelial [Ca2+]i (Gautam et al., 1998). This results in cytoskeletal 
changes caused by increased interaction between actin and myosin light chain, and 
oxidant production in the endothelial cell (Wang & Doerschuk, 2002). Blockade of 
the Ca2+ mobilization (Huang et al., 1993; Gautam et al., 2000) or MLC 
phosphorylation (Yuan et al., 2002) prevents the PMN-induced permeability increase. 
It has been shown, using in vitro models, that blockade of ICAM-1 inhibits these 
cytoskeletal changes and that cross-linking of ICAM-1 is able to activate several 
signaling molecules (such as PKC, Rho, Src family kinases and Ca2+) that could lead 
to cytoskeletal reorganization (Wang & Doerschuk, 2002). Engagement of ICAM-1 
leads to activation of the tyrosine kinases Src and Pyk2, which is required for 
phosphorylation of VE-cadherin, which in turn is required for PMN transmigration 
(Allingham et al., 2007). PMN binding to TNFα-activated EC initiates the 
dissociation of VE-PTP from VE-cadherin which weakens the VE-cadherin function. 
This dissociation was independent of EC adhesion molecules or oxygen free radicals 
(Nottebaum et al., 2008).  
 
Neutrophil-secretion as a mechanism for increased permeability 
Outside-in signaling by β2-integrins triggers the secretion of PMN-derived factors that 
cause permeability increases independent of activation of endothelial receptors 
(Gautam et al., 2000). As described earlier, PMN contain three types of granules as 
wells as secretory vesicles that are released in a timely fashion during the recruitment 
process (Borregaard et al., 2007). Several of the granule proteins such as neutrophil 
elastase, cathepsin G and HBP have been shown to be capable of increasing vascular 
permeability (DiStasi & Ley, 2009).  
Neutrophil elastase and cathepsin G are present on the cell surface of transmigrating 
PMN in vitro and are able to cleave VE cadherin thus disrupting the EC monolayer 
(Hermant et al., 2003). Membrane bound elastase will be protected from protease 
inhibitors in the plasma, which allows for targeting of the enzymatic activity to 
junctions where transmigration occurs. Elastase has been found to be localized to the 
leading front of transmigrating cells (Cepinskas et al., 1999). On the contrary, mice 
that are deficient in elastase exhibit, despite an attenuation of the number of recruited 
PMN, an increase in permeability (Kaynar et al., 2008) possibly due to longer 
adhesion time at the endothelium. In an in vitro model of the endothelial barrier, 
selective removal of elastase and cathepsin G from supernatants of activated PMN 
had no effect on the permeability increasing activity of the PMN supernatants 
(Gautam et al., 2001). The role for elastase in PMN-induced permeability increase is 
disputed also by the time span and prestimulation required for increased permeability 
to occur (Smedly et al., 1986), presumably due to the slow mobilization of elastase 
from the primary granules. Further, it is not clear if adherent or transmigrating PMN 
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release granules beyond secretory vesicles (DiStasi & Ley, 2009).Few studies have 
investigated the role of elastase and cathepsin G in vivo.  
Opposed to what has been suggested for elastase and cathepsin G, neutrophil granule 
proteins may not act to increase permeability using a proteolytic effect but rather via 
charge interactions (Peterson et al., 1987; Peterson, 1989; Rosengren & Arfors, 1990, 
1991; Gautam et al., 2001). The inactive serine protease family member HBP, which 
is released from PMN upon β2 ligation (Figure 1B), has also been suggested as a link 
in PMN-induced alterations of vascular permeability (Gautam et al., 2001). It is 
stored in the primary granules together with elastase, cathepsin G and proteinase 3, 
but a substantial part is located also in the secretory vesicles and can therefore be 
mobilized more rapidly than the other serine proteases (Tapper et al., 2002). HBP 
binds to surface proteoglycans on the EC, probably via its concentration of strong 
positively charged aminoacids that creates a strong dipole moment (Gautam et al., 
2001). However, the mechanism behind charge dependent increases in permeability 
remains unknown.  
 
Reactive oxygen species-induced mechanisms of vascular permeability. 
Neutrophils are able to produce highly reactive oxygen species through their granule 
contents and although these are intended for microbicidal effects in the tissue and 
should not be released in the blood stream it is possible that these ROS contribute to 
alterations in permeability (Dallegri & Ottonello, 1997). ROS may cause increased 
permeability either via direct damage to the endothelial cell, or activation of signaling 
pathways leading to increased intracellular Ca2+, MLCK activation and cytoskeletal 
reorganization (Lindbom, 2003). 
As these products are highly reactive and thus potentially harmful to the tissue it 
seems unphysiological for them to be released at the endothelium to increase 
permeability. Still there is evidence to support that ROS may cause disruption of the 
endothelial barrier through cell disintegration, increased Ca2+, MLCK activation and 
junctional protein reorganization (Lindbom, 2003). In addition, endothelial cells are 
able to produce these ROS as a consequence of PMN activation (Wang & Doerschuk, 
2002). However, there is evidence to dispute the role of PMN-induced ROS formation 
leading to increased vascular permeability (Harlan et al., 1985; Rosengren et al., 1988; 
Kaslovsky et al., 1990). Oxidants have been shown to stimulate endothelial cells to 
express PMN adhesion molecules and this may be an indirect reason for ROS-induced 
alterations in endothelial barrier function (Lo et al., 1993). Additionally, clinical trials 
with antioxidant therapy to prevent edema formation have been unsuccessful (Boueiz 
& Hassoun, 2009).  
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THE BLOOD-BRAIN BARRIER AND FORMATION OF CEREBRAL EDEMA 
As already mentioned, the BBB includes a specialized endothelium limited to vessels 
of the central nervous system (CNS). The endothelial junctions are structurally 
different from those in the peripheral endothelium and therefore the formation of 
cerebral edema requires special attention.  
The Blood Brain Barrier 
Through a complex network of tight junctions, the endothelium making up the BBB 
restricts diffusion of water-soluble molecules across the vessel wall. Pericytes 
surround endothelial cells with their pseudopodia and support the barrier function of 
the endothelium. The BBB protects the brain from noxious stimuli by tight control of 
trans- and paracellular transportation processes. Intact BBB does not easily let 
through blood components larger than 20 kDa and the transport of substances into the 
brain depends on the size and lipid solubility of the molecule as well as the presence 
of specific carrier systems (Scholz et al., 2007). Maintenance of ion homeostasis is 
crucial because of its importance for neuronal function and as proteins such as 
albumin and plasminogen are damaging to nervous tissue, it is crucial that the BBB 
prevents macromolecule leakage from the blood (Abbott et al., 2010). 
The BBB consists of three layers: endothelium, basal membrane, and astrocyte 
pseudopodia. Microvessel endothelial cell association with astrocytic glia endfeet, 
contributes to the specialized BBB phenotype. The morphology, biochemistry and 
function distinguish these EC from those making up the endothelial lining in 
peripheral tissue (Engelhardt & Sorokin, 2009). In addition to the adherens junctions 
that promote endothelial barrier function in the peripheral tissue, the BBB has well 
developed tight junctions that are responsible for the restriction of diffusion (Wolburg 
et al., 2009). This junctional complex consists of occludins and claudins that span the 
intercellular cleft together with JAM. The regulatory proteins zonula occludens (ZO)-
1 to -3 and cingulin link occludin and claudin to the cytoskeleton. Dysfunction of the 
BBB is associated with several CNS pathologies such as multiple sclerosis, viral and 
bacterial infections, skull trauma and stroke (Abbott et al., 2010). 
 
Cerebral edema 
Brain edema is a result of structural and functional changes of the BBB, 
microcirculation, and cell volume regulation. Edema can be classified as cytotoxic or 
vasogenic. Two additional categories of brain edema include interstitial edema seen in 
patients with hydrocephalus and “osmotic” edema caused by electrolyte imbalances 
leading to water influx into cells (Unterberg et al., 2004). Vasogenic edema results 
from extracellular water accumulation due to loss of BBB integrity or disturbed 
microcirculation, and is characterized by normal cell size and increased interstitial 
space. The BBB dysfunction could be the effect of mechanical injury or inflammatory 
mediators or a combination of both. Paracellular permeability is the major pathway 
for plasma leakage across the BBB (Abbott et al., 2010) and disruption of the BBB is 
characterized by intracellular gap formation, changes in cell shape, cytoskeletal 
reorganization and redistribution of endothelial junctional proteins (Stamatovic et al., 
2006).  
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Cytotoxic edema occurs as a result of intracellular swelling of glia and neurons 
because of water accumulation due to cellular injury. This form of edema may arise 
independently of the integrity of the BBB and is characterized by cell swelling and 
decreased interstitial space (Unterberg et al., 2004). Osmotic/interstitial brain edema 
is usually caused by serum hypoosmolarity but can also be the result of 
hyperosmolarity of the cerebral tissue as seen following ischemia or traumatic brain 
injury (TBI) where necrotic tissue can have high osmolality. Traditionally, cerebral 
edema following TBI has been considered as vasogenic, especially around contusions. 
It is now known that cytotoxic edema also is of significant importance (Unterberg et 
al., 2004). 
 
Inflammation and brain edema – role for neutrophils? 
The CNS has historically been thought to be an immunologically privileged organ 
because of the tight blood brain barrier. However, more recent research has shown 
that several cell-types such as neurons, astrocytes and microglia are able to synthesize 
immune mediators and it is now accepted that injury to the brain can elicit a potent 
immune response (Schmidt et al., 2005). The barrier function can be modified by 
inflammatory events such as leukocyte activation and release of free radicals and 
inflammatory mediators like histamine, bradykinin, TNFα or IL-1, that are also 
known to affect vascular permeability in peripheral tissue (Scholz et al., 2007; Abbott 
et al., 2010). Proinflammatory cytokines and oxidative mediators participate in BBB 
disruption either directly or via other mediators thus causing brain edema (Stamatovic 
et al., 2006). In the brain, the endothelium is mainly activated by local release of 
cytokines from parenchymal or vascular cells (Scholz et al., 2007). The 
neuroinflammatory response includes activation of gial cells, intrathecal release of 
proinflammatory cytokines and chemokines, upregulation of EC adhesion molecules 
and intracranial complement activation (Schmidt et al., 2004).  
Neutrophils are able to enter the brain through transendothelial migration across the 
BBB or by direct migration from the blood stream during a hemorrhage (Joice et al., 
2009). The ability of neutrophils to exacerbate injury has been shown in several CNS 
conditions (Bednar et al., 1997). During the first 24 hours following TBI, there is a 
recruitment of PMN into the brain parenchyma and possibly a relationship between 
cortical PMN accumulation and secondary brain injury (Zhuang et al., 1993). 
Activation of PMN is tightly associated with the production and secretion of 
cytokines/chemokines and the release of oxygen radicals and proteases (Scholz et al., 
2007). 
Leukocyte recruitment across the BBB is associated with the activation of signaling 
cascades leading to the loss of TJ proteins occludin and ZO-1 and redistribution of AJ 
proteins (Bolton et al., 1998). This may explain the significant correlation between 
PMN accumulation and brain edema (Schoettle et al., 1990). In addition, the CXC 
chemokine IL-8, which causes PMN recruitment, is associated with BBB dysfunction 
(Kossmann et al., 1997) and clinical outcome following TBI (Whalen et al., 2000). 
However, whether there is a causal relationship between the two remains to be 
determined as there is evidence both for (Schoettle et al., 1990) and against (Whalen 
et al., 1999) a role of PMN in cerebral edema formation.  
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AIMS  
 
The overall aim of this thesis was to further elucidate mechanisms controlling 
leukocyte extravasation and concurrent alterations in vascular permeability in acute 
inflammation. More specifically, the studies aimed at investigating: 
1. The importance of the basement membrane protein laminin-411 in leukocyte 
recruitment to extravascular tissue. 
2. The mechanistic basis behind neutrophil-induced alteration of vascular 
permeability. 
3. The role of neutrophils in the edema formation following traumatic brain 
injury. 
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EXPERIMENTAL PROCEDURES 
 
The studies included in this thesis are based on a combined use of in vivo models and 
in vitro methodology adapted to the specific research questions. For a more detailed 
description of the methods used, see the individual papers.  
 
IN VIVO METHODOLOGY 
As the immune system of animals is broadly similar across species and the 
inflammatory mediators in humans usually have homologous counterparts in rodents, 
the use of rodent models to study inflammation is invaluable (Moore, 2003). A 
multitude of in vivo models have been developed to study the inflammatory process. 
These range from simple screening-type models to more complex models such as 
intravital microscopy of exposed tissues. 
 
Inflammation of the ear skin (paper I) 
Inflammation of the ear skin is a well established and commonly used model, where 
an inflammatory stimulus is applied to one ear using the other ear as a control. Several 
different substances can be used to induce inflammation (e.g. croton oil, mustard oil 
and zymosan) and ear thickness or weight is used as a measure of the inflammatory 
response (Gabor, 2003). Results are often expressed as a ratio between the inflamed 
and control ear. In paper I, croton oil application to the right ear was used as a 
stimulus to induce an acute inflammatory reaction. The left ear served as a control. 
Mice were sacrificed five hours later and ear pieces were removed using a dermal 
punch, and weighed.  
A delayed time hypersensitivity (DTH) reaction was also induced in the ear skin. In 
this model mice were sensitized through application of 1-Fluoro-2,4-dinitrobenzene 
(DNFB) on the rear foot pad for two days. Four days later the mice were challenged 
by application of DNFB to the right ear and measurements were performed after 24 
hours. In contrast to croton oil-induced inflammation, which is a crude model 
resulting in recruitment of several leukocyte subclasses, lymphocytes constitute the 
predominant cell type infiltrating the tissue in response to DNFB (Phanuphak et al., 
1974).  
Both ear models are quick and simple, require small quantities of substances and 
provide well-reproducible results. However, without histological examination of the 
ears, the composition of the exudate, which causes increased ear weight and thickness, 
cannot be specified. Further examinations using models that allow for such analysis 
should therefore be performed as a complement. 
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Cavity models (paper I, II and III) 
Slightly more complex techniques than the ear skin model are represented by different 
cavity models, such as the subcutaneous air pouch, peritonitis and pleurisy. In these 
models, an inflammatory stimulus is injected into a physiological or artificial cavity 
and the exudate is harvested and analyzed (Moore, 2003). In this thesis, the 
subcutaneous air pouch and pleurisy models were used, and as they have different 
characteristics they can be used in combination to achieve a better understanding of 
the complex inflammatory process.  
The air pouch model involves the creation of a subcutaneous pocket on the back of 
the mouse. Air is injected twice over 4-6 days and the inflammatory substance is then 
injected and exudate can be harvested at several time points later (Colville-Nash & 
Lawrence, 2003). One advantage of this model is that as the air pouch is an artificial 
cavity so the number of resident cells that interfere with the inflammatory response 
are few. This model also allows for the use of a multitude of stimuli and treatment 
times. Finally, it is minimally invasive and many mice can be treated simultaneously. 
In paper I, MCP-1 was injected into the pouch to stimulate recruitment of monocytes 
specifically. Mice were sacrificed 24 hours after injection, the pouch was lavaged and 
the collected cells were differentiated using flow cytometry.  
Pleurisy is a more advanced cavity model as it allows for parallel assessment of 
vascular permeability and leukocyte recruitment. Induction of pleurisy is performed 
through direct injection of the irritant to the pleural cavity in anaesthetized mice or 
rats. A fluorescently labeled macromolecule is administered intravenously as a plasma 
marker and following sacrifice, the pleural exudate is collected, and its volume 
measured and analyzed for leukocyte and macromolecule content. The most common 
models of pleurisy use carrageenan as the inflammatory stimulus (Moore, 2003). We 
found however that the permeability increase using this irritant was not solely PMN-
dependent and since this was important to test our hypothesis we used thioglycollate 
instead (paper I and III). Thioglycollate is known to become more potent over time 
(Li et al., 1997), and therefore control experiments were always performed together 
with the treatments. In paper II, pleurisy was induced using LTB4.  
Prior to surgical intervention, mice were anaesthetized and a jugular vein catheter was 
placed for intravenous access. As this model requires invasive surgery, the mice were 
kept anaesthetized during the whole experiment. FITC-dextran was used as a plasma 
macromolecule tracer. Mice were sacrificed four hours after the intrapleural injection 
of stimulant. A blood sample was taken to determine the serum level of fluorescein 
isothiocyanate (FITC)-dextran and the exudate in the pleural cavity was removed for 
analysis of macromolecule and leukocyte content.  
 
Intravital microscopy (paper I and III) 
Intravital microscopy (IVM) allows for a more thorough investigation of leukocyte 
recruitment and alteration of vascular permeability than previously described models. 
The investigated tissue in an anaesthetized animal is exteriorized and observed with a 
microscope. Using a camera and recording of images, it is possible to analyze 
microcirculatory parameters such as leukocyte behavior and permeability changes in 
real time. IVM provides information about the different steps in the leukocyte 
extravasation cascade (rolling, adhesion, transmigration and extravascular migration). 
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Chemoattractants can be applied in several manners; superfusion, interstitial 
microinjection, intravenous injection, or by placing a gel containing a chemoattractant 
at a specific distance from the venule (Cara & Kubes, 2004). Vascular permeability 
changes can be investigated by intravenous injection of a fluorescent plasma marker 
(Raud & Lindbom, 1994). The method has previously been limited to tissues that can 
be easily transilluminated, e.g. cremaster muscle and mesentery in mouse and rat, and 
the hamster cheek pouch. However, as the method has been further developed it is 
now possible, using fluorescent microscopy, to study tissues such as the brain, liver, 
large arteries and heart (Cara & Kubes, 2004). In this thesis IVM of the mouse 
cremaster muscle (paper I) and hamster cheek pouch (paper III) was used.  
The mouse cremaster is commonly used for assessment of leukocyte recruitment. 
Rolling cells are classified as those moving slower than red blood cells, adherent cells 
as those remaining stationary for a set amount of time and extravasated cells are 
counted in a predetermined distance from a post-capillary venule. Extravascular 
migration can be assessed using transillumination and time-lapse video microscopy. 
Due to the skeletal muscle striations, it is easy to detect extravasated cells using this 
model. In paper I, PAF was added to the superfusion to stimulate leukocyte 
recruitment and the number of adherent and extravascular cells was counted before 
and after a 60 min period. For assessment of extravascular migration velocity, 60 min 
recordings were made with time-lapse video microscopy and the distances traveled by 
leukocytes were analyzed off-line. 
The hamster cheek pouch was used, in paper III, to simultaneously assess changes in 
vascular permeability and leukocyte adhesion, which was stimulated with the addition 
of LTB4 to the superfusion solution. Leukocyte independent plasma leakage was 
induced by topical administration of bradykinin. Vascular permeability was assessed 
using an intravenous injection of FITC-dextran, and transillumination with excitatory 
fluorescent light. Quantification of leakage from the vessels can be performed using 
several methods. The leakage sites can be counted under low magnification. Another 
possibility is to collect the superfusion fluid and measure its fluorescent content (Raud 
& Lindbom, 1994). In our experiments, we used photodensitometric determination of 
images taken. A drawback to this method of measuring permeability is that is does not 
measure the inflammatory response of a whole tissue. On the other hand, it allows for 
detailed temporal and spatial determination of leakage sites. 
It is important to maintain physiological conditions by minimizing the “unspecific” 
inflammation resulting from preparative surgery and establishing a physiologic 
environment around the preparation with respect to temperature, extracellular fluid 
composition, pH and gas tension (Raud & Lindbom, 1994). Blood flow should also be 
controlled as this might affect leukocyte function and vascular permeability. We 
found that PGE2 should be added to the superfusion for optimal blood flow in the 
hamster cheek pouch. There is a fine line between preparing the tissue well enough to 
obtain good images and on the other hand causing damage to the tissue, which may 
affect both leukocyte behavior and vascular permeability. Leukocyte rolling as a 
consequence of the preparative procedure is very difficult to prevent, but adhesion 
and extravasated cells should be minimal following surgical preparation. A major 
drawback to intravital microscopy is that it is time-consuming because of delicate 
surgery and that the technique allows study of only one animal at a time. There is also 
a risk for bias when choosing the locations to be measured. We therefore analyzed 4-6 
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pre-determined areas in each preparation and followed them throughout the 
experiment. 
 
Traumatic brain injury (paper IV) 
TBI is a multifaceted condition and no single experimental technique can reproduce 
all of its characteristics. A major challenge with trying to model TBI is that real-life 
injury may vary with respect to location, cause and severity. Therefore, several 
different models are available out of which the most common are the weight drop, 
impact acceleration, controlled cortical impact (CCI) and fluid percussion models. 
Except for the impact acceleration model, which results in a diffuse injury, these 
models cause focal brain injury (Morales et al., 2005). 
The CCI model was first described in the rat by Dixon et. al. (Dixon et al., 1991) and 
uses mechanical energy to induce damage. It uses a pneumatically driven piston, 
which impacts a localized area of the exposed dura. This model results in less 
mortality and apnea than the fluid percussion model due to decreased involvement of 
the brain stem (Dixon et al., 1991). The site of injury can be either along the midline 
or lateral cortex. The decrease in mortality compared to other models can be both of 
advantage and disadvantage depending on the hypothesis being tested. A strong 
positive side to this model is the ability to control the severity of the injury by altering 
the time, velocity and depth of the impact. Also, with the same operator, the extent of 
injury is very reproducible. The damage caused by CCI is predominantly focal and 
has been shown to cause acute subdural hematoma, axonal injury, concussion, BBB 
dysfunction and coma (Morales et al., 2005).  
In paper IV, CCI in mice was used as a model of TBI. Mice were anesthetized and 
cortical contusion was delivered by a piston to the right hemisphere. Depending on 
the outcome measurement, mice were sacrificed 24 hours to 14 days later. To 
determine lesion size, sections of right and left hemispheres were stained and 
photographed. Immunohistochemistry and antibody staining was used to assess 
parenchymal cell apoptosis and microglial activation. Two methods were used to 
determine edema formation; brain water content and Evan’s blue extravasation. 
Brains were weighed directly after removal and again after drying to assess water 
content. Evan’s blue, which binds to albumin in the blood, was injected intravenously 
via the tail vein after CCI. Extravasation of the dye after injury was assessed 
spectrophotometrically following extraction from brain tissue in formamide.  
 
IN VITRO METHODOLOGY 
Although inflammation, with characteristical recruitment of leukocytes and increase 
in vascular permeability, is a complex process hard to model using in vitro systems, 
the importance of such techniques should not be overlooked. They allow for direct 
observation, quantitative analysis and manipulation of inflammatory parameters that 
are currently not possible to track in vivo (Muller & Luscinskas, 2008). Most in vitro 
model systems focusing on the inflammatory reaction take advantage of leukocytes 
isolated from whole blood and cultured endothelial cells.  
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Endothelial cell culture (paper II and III) 
In vitro, EC monolayers have been widely used to model the vessel wall and to study 
adhesive interactions of immune cells in the microvasculature. Although using 
cultured EC to model inflammatory reactions is convenient and versatile, there are 
some limitations to their use. For example, EC from different organs and/or species 
behave differently in culture. Furthermore, there might be a difference in the behavior 
of micro- and macrovascular EC, and because inflammation generally takes place in 
the microcirculation, this difference may be of importance (Kvietys & Granger, 1997). 
In vivo, endothelial cells are constantly exposed to shear stress and EC that are 
cultured under shear have been shown to express more developed adherens and tight 
junctions (Noria et al., 1999; Colgan et al., 2007). However, the role of shear stress in 
EC culture is yet to be fully understood (Tarbell, 2010).  
Human umbilical vein endothelial cells (HUVEC) were used in paper II and III. In 
paper II, Ca2+ mobilization in HUVEC was assessed using the Calcium indicator 
FURA-2AM., In paper III, HUVEC were used to investigate proteolysis of HK 
induced by PMN. HUVEC were incubated with human plasma and neutrophils were 
then added and activated with IL-8. Western blotting was used to detect intact HK in 
cell lysates. 
 
Human neutrophils (paper I, II and III) 
Neutrophils from human venous blood were used in paper I, II and III. Cells were 
isolated using conventional separation media and red blood cells were subjected to 
hypotonic lysis. In paper I, neutrophil migration on laminin-411 or -511 was induced 
by IL-8 in a modified Boyden chamber chemotaxis assay. Migrated cells were 
collected and analyzed by flow cytometry. In another set of experiments neutrophil 
adhesion to laminin-411 and -511 was stimulated using IL-8. Adherent cells were 
quantified through analysis of MPO activity (Suzuki et al., 1983). In paper II, isolated 
PMN were stimulated with LTB4 to induce degranulation. Cells were spun down and 
the supernatant, containing neutrophil granule proteins, were used to stimulate 
endothelial cells in vitro and to induce vascular permeability in vivo.  
. 
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RESULTS AND DISCUSSION 
 
 
The cardinal signs of inflammation have been known for two thousand years and 
much research has been performed to clarify the mechanisms that lead to the 
recruitment of leukocytes and alterations in vascular permeability. However, many 
details remain unclear. With the use of in vivo techniques and in vitro methodology, 
this thesis aimed at further elucidating the interplay between emigrating leukocytes 
and the vessel wall in acute inflammation.  
 
Inflammatory cell migration across the vessel wall is dependent on the 
presence of laminin α4 in the basement membrane (paper I) 
Leukocyte recruitment in inflammation involves migration across the endothelium 
and the perivascular basement membrane, which consists of a dense network of 
matrix proteins such as laminin-411, -511, collagen IV and nidogen. Laminin-411 has 
been identified as an important structural and signaling molecule in the vascular BM. 
To investigate the role of laminin-411 in inflammatory cell recruitment, we used 
several in vivo recruitment models and compared responses in WT and Lam4-/- mice.  
Two different approaches were used to stimulate leukocyte extravasation in the mouse 
ear skin. In the first setting, croton oil was topically applied to the skin of the ear. 
Croton oil is known to trigger an unspecific inflammatory reaction that involves 
recruitment of different leukocyte subclasses. In a second approach, a DTH reaction 
was induced in the ear skin. Local challenge following sensitization with DNFB 
results in preferential recruitment of lymphocytes (Phanuphak et al., 1974). In both 
models we found that the ratio between right and left ear weight was significantly 
smaller in the Lam4-/- mice compared to WT indicating a reduced inflammatory 
response (Figure 2A,B). As different types of leukocytes may use discrete 
mechanisms for extravasation, we applied additional recruitment models, the 
subcutaneous air pouch and thioglycollate-induced pleurisy to investigate monocyte 
and neutrophil recruitment, respectively. Monocyte recruitment to the air pouch 
stimulated by the chemoattractant MCP-1 was significantly attenuated in Lam4-/- 
mice, clearly indicating that laminin-411 is required for effective monocyte 
extravasation (Figure 2C). PMN recruitment as a response to thioglycollate-induced 
pleurisy was significantly reduced in mice lacking laminin-411 compared to WT mice 
(Figure 2D).  
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We established that deficiency in laminin-411 affects recruitment of all three major 
leukocyte subsets. Further experiments were undertaken to identify which step in the 
extravasation cascade that was impaired. For this purpose we used intravital 
microscopy to view the interactions between leukocytes and endothelial cells in 
venules of the cremaster muscle allowing analysis of leukocyte adhesion to the 
endothelium, transendothelial migration, and interstitial migration. Confirming our 
initial data, there was a decrease in recruitment of leukocytes to the extravascular 
space in Lam4-/- mice (Figure 3A). There was however no reduction in the number of 
adherent cells in the mice lacking the laminin α4 chain, rather vice versa, indicating 
that the decrease in leukocyte recruitment is not due to a defect in adhesion but more 
Figure 2. Leukocyte recruitment is 
impaired in Lam4-/- mice. A, B) Local 
skin inflammation in the ear was induced by
topical application of croton oil (A, n=4) or 
challenge with DFNB in sensitized animals 
(B, n=6). The inflammatory response was 
assessed as tissue swelling and presented as 
the ratio between right (inflamed) and left 
(control) ear weight in WT (filled bars) and 
Lam4-/- (open bars) mice. C) Monocyte 
recruitment to a subcutaneous air pouch 24 
hours after stimulation with 100 ng rmMCP-
1 in WT (n=5) and Lam4-/- (n=5) mice. D)
Pleurisy was induced by injection of 100 μl 
thioglycollate into the pleural cavity in WT 
(n=7) and Lam4-/- (n=7) mice, and 
neutrophil accumulation was assessed four 
hours later. Stimulation with sterile PBS 
was used as negative control (dashed line). * 
indicates significant difference at P<0.05. 
Values are mean ± SEM. 
Figure 3. Attenuated leukocyte recruitment in Lam4-/- mice is due to impaired
migration through the vessel wall. A) Leukocyte extravasation in the cremaster muscle
was induced by local stimulation with 100 nM PAF in WT (n=4, filled bars) and Lam4-/-
(n=5, open bars) mice. Adherent (ADH) and extravasated (EV) cells per field were 
determined by IVM after a 60 min stimulation period. * indicates significant difference
at P<0.05. Values are mean ± SEM. B) Migratory speed of emigrated cells was measured
using intravital time-lapse video microscopy for 60 min in WT (n=3, 44 cells) and
Lam4-/- (n=3, 50 cells) mice.  
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likely related to impaired migration across the vessel wall. Yet another cause for 
reduced leukocyte recruitment could be less efficient migration in the extravascular 
tissue (Lindbom & Werr, 2002). However, we did not find a reduction in migration 
velocity in the Lam4-/- mice compared to WT indicating that the locomotor response 
was intact (Figure 3B). Collectively, the findings obtained by IVM show that 
intravascular adhesion to the endothelial lining as well as migratory capacity in the 
extravascular tissue is not compromised in Lam4-/- mice, suggesting an impaired 
ability to penetrate the vessel wall in these mice as a principal cause for reduced 
leukocyte recruitment.  
That loss of a structural component of the vascular basement membrane results in a 
less effective transmigration may seem surprising as one might expect that an 
incomplete barrier would rather facilitate cell passage. However, there are data to 
suggest that interaction with laminin-411 may positively influence leukocyte motility. 
Mononuclear leukocyte migration has previously been found to be more vigorous on 
laminin-411 than on laminin-511 (Pedraza et al., 2000; Geberhiwot et al., 2001; Wu 
et al., 2009). We compared migration of neutrophils on these two laminin isoforms 
but there was no preferential migration of this leukocyte subset on laminin-411 
relative to laminin-511. On the other hand, we found that neutrophil adhesion to 
laminin-511 under stationary conditions was enhanced compared to laminin-411.  
The mechanism behind decreased recruitment in laminin α4 chain deficient mice 
remains unclear, but there are several possible explanations. Similar to what was 
reported for tumor cell migration (Vainionpaa et al., 2007) it is conceivable that 
recognition of laminin-411 in the subendothelial basement membrane and signaling 
via laminin-binding receptors, such as integrin α6β1, stimulates detachment of the rear 
of the leukocyte from the endothelium and thereby promotes forward migration 
through the vessel wall. This hypothesis is consistent with our finding of an increased 
number of adherent leukocytes to EC in Lam4-/- mice. 
Laminin-511 has, contrary to the indicated role of laminin-411, been suggested to 
exert a restraining influence on leukocyte migration through the vessel wall. It was 
shown that leukocytes preferentially penetrate the basement membrane at sites low in 
expression of laminin-511 (Sixt et al., 2001; Wang et al., 2006; Voisin et al., 2010). 
As mice lacking the laminin α4 chain reportedly exhibit a more uniform expression of 
laminin-511 along the vessel wall (Wu et al., 2009), a shift in the distribution between 
these laminin isoforms could potentially explain the suppressed recruitment in 
Lam4-/- mice. Another possibility lies in the structure of the laminin α4 chain. 
Contrary to the other laminin α chains, the α4 chain is truncated which may reduce 
cross-linking with collagen IV (Hallmann et al., 2005). This might facilitate migration 
through basement membranes high in laminin α4 chain as they are not as tightly 
intertwined. It was, however, not possible to detect any overt change in the 
distribution of Laminin-511 when comparing our histology specimens from WT and 
Lam4-/- mice. The postulated contrasting roles of laminin-411 and laminin-511 may 
seem surprising as the interaction between leukocytes and both laminin isoforms is 
mediated chiefly by the α6β1 integrin (Geberhiwot et al., 2001; Gu et al., 2003). On 
the other hand, recent data show that migration across laminin-411 is inhibited with 
antibodies blocking the α6 and β1 integrins, whereas migration over laminin-511 is 
unaffected by this treatment (Wu et al., 2009).  
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Neutrophils induce alterations in vascular permeability during acute 
inflammation (paper II and III) 
It has been known for long that there is an increase in vascular permeability in 
conjunction with PMN recruitment in acute inflammation (Wedmore & Williams, 
1981). The lipid mediator LTB4 is a potent chemoattractant for PMN, and is known to 
stimulate enhanced vascular permeability through triggering PMN extravasation 
(Bjork et al., 1982; Rosengren et al., 1991). Neutrophil activation and release of 
granule protein HBP has previously been suggested to be a key mechanism behind 
PMN-induced changes in vascular permeability (Gautam et al., 2001). However, the 
link between these two mediators is unknown and it was of interest to investigate a 
possible cross-talk between them.  
Western blot analysis showed that stimulation of PMN with LTB4 induced an 
immediate release of HBP. Degranulation of PMN as a result of LTB4 stimulation is 
mediated by the BLT1 receptor as HBP release was completely inhibited in PMN 
treated with an antagonist to the BLT1 receptor. Neutrophil degranulation is known to 
involve different kinases such as p38 mitogen-activated protein-kinase and 1-
phosphatidylinositol 3-kinase (PI3K) (Mocsai et al., 2000; Gaudreault et al., 2005; 
Nanamori et al., 2007). We show that the BLT1 receptor signals via the Src family 
kinases and more specifically PI3K, which result in degranulation and the release of 
HBP.  
The bioactivity of the PMN supernatant was tested on cultured ECs. Supernatant from 
LTB4 stimulated PMN triggered a rise in EC [Ca2+]i. This response was attenuated in 
supernatant from PMN that were treated with a BLT1 receptor antagonist and 
supernatant where HBP was removed by immunoadsorption (Figure 4A). To further 
examine the relationship between LTB4  challenge and PMN degranulation in vivo, 
pleurisy was induced in mice through injection of LTB4 in the pleural cavity. The 
plasma extravasation induced by LTB4 stimulation was abolished in mice that were 
depleted of PMN indicating that the response was PMN-dependent and that LTB4 
alone does not affect the endothelial cell permeability. Treatment of mice with a 
BLT1 receptor antagonist also attenuated this response. Intrapleural injection of the 
same supernatants as used for EC Ca2+ mobilization experiments showed that 
Figure 4. HBP released from LTB4-treated PMN induce intracellular calcium mobilization in vitro and 
increased vascular permeability in vivo. A) Supernatant (50 μl) from untreated PMNs (CTRL; n=3), LTB4-treated 
PMNs (LTB4; n=3), CP105696-pretreated PMNs (CP, CP105696; n=3), or supernatant depleted of HBP (HBP 
depleted; n=3) was added to microwells of endothelial cell monolayers, and intracellular Ca2+ mobilization was 
monitored. Data are expressed as relative MFI. B) The same supernatans (100 μl) were injected into the pleural
space in PMN-depleted mice (n=4). After 4 h, exudate in the pleural cavity was collected for assessment of plasma
extravasation (expressed as plasma clearance volume of intravenously injected FITC-dextran). Values are mean ± 
SEM. * indicates significant difference at P<0.05, and ** at P<0.01. 
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supernatant from LTB4-treated PMN induces a significant increase in vascular 
permeability. Moreover immunoadsorption of HBP rendered the postsecretory 
supernatant inactive with respect to causing a change in vascular permeability (Figure 
4B). These data agree with results obtained in EC [Ca2+]i mobilization experiments 
and confirm that HBP released from LTB4-stimulated PMN is not only biologically 
active but may also contribute to enhanced plasma extravasation during leukotriene-
dependent inflammation. 
To further clarify the mechanism how neutrophil granule proteins induce increases in 
vascular permeability it was of interest to investigate the involvement of the 
kallikrein-kinin system. Components of the kallikrein-kinin system, i.e. PK, FXII, and 
HK, assemble on the surface of EC and PMN where these proteins may be susceptible 
to attack from granule proteins released from PMN as they adhere to EC. Initial 
experiments aimed at elucidating whether PMN are capable of triggering activation of 
the kallikrein-kinin system on the EC surface. Endothelial cells were incubated with 
plasma, which resulted in binding of HK, and subsequently exposed to PMN that in 
some samples were activated with IL-8. Incubation with PMN alone or to a greater 
extent PMN stimulated with IL-8 triggered HK breakdown (Figure 5A). Kaolin, 
which results in a complete proteolysis served as a positive control. These data 
indicate that stimulated PMN can initiate activation of the kallikrein-kinin system 
leading to the proteolysis of high molecular weight kininogen.  
Additional investigations of the role of the kallikrein-kinin system in neutrophil 
evoked plasma exudation in vivo, used the mouse pleurisy and the hamster cheek 
pouch models. Thioglycollate-induced pleurisy resulted in profound plasma 
exudation, which was neutrophil-dependent (Figure 5B). Combined treatment with 
kinin B1 and B2 receptor antagonists largely prevented the PMN-induced plasma 
leakage. Treatment with two different PK inhibitors, H-D-Pro-Phe-Arg-
chloromethylketone (CMK) or VA999026, to prevent kinin formation was almost as 
Figure 5. Neutrophil-induced plasma exudation is the result of degradation of high molecular weight 
kininogen. A) Upper panel; representative Western blot of HK. Lower panel; density quantification of Western blot
as percentage of control (HUVEC treated with plasma). HUVEC were incubated with human plasma (lane 1, n=11)
and treated with kaolin (lane 2, n=11), PMN (lane 3, n=7) or PMN stimulated with IL-8 (lane 4, n=11). Values are 
mean ± SD. * represents significant difference from control, # represents significant difference from PMN. B, C) 
Plasma exudation, represented as permeability index, in mouse pleurisy following treatment with (B) PBS (negative 
control, n=5), thioglycollate (Thio, n=7), anti-Gr1 antibody (PMN depl, n=5) and anti-CD18 antibody (CD18Ab, 
n=5). (C) Interference with the kallikrein-kinin system was performed using kinin B1 and B2 receptor antagonists 
(B1 + B2 ant, n=5), CMK (n=6), plasma kallikrein inhibitor (PK inh, n=8), or tissue kallikrein inhibitor (TK inh,
n=8). Dashed line represents values for PBS treatment. Values are mean ± SD. * represents significant difference 
from Thio. 
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effective as the kinin receptor blockade in preventing the PMN-evoked plasma 
exudation (Figure 5C). These findings were confirmed in the hamster cheek pouch 
model. The increase in vascular permeability caused by activated PMN was annulled 
by combined treatment with kinin B1 and B2 receptor antagonists. Additionally, in 
hamsters pre-treated with the specific PK inhibitor VA999026, the increase in venular 
permeability evoked by adherent PMN was essentially abolished. The cheek pouch 
venules were, however, still responsive to bradykinin (Figure 6A). Importantly, the 
number of adherent leukocytes in venules was not significantly reduced by treatment 
with either the PK inhibitors or the kinin receptor antagonists (Figure 6B) indicating 
that the suppression of plasma leakage in the in vivo models is not due to decreased 
leukocyte adhesion as a result of treatment with inhibitors.  
It was previously reported that ligation of β2 integrins triggers PMN degranulation 
and release of granule proteins, which stimulate cytoskeletal rearrangement and 
hyperpermeability in adjacent EC (Gautam et al., 2000; Gautam et al., 2001). Here we 
show that stimulation of PMN with the known chemoattractant LTB4 results in a 
supernatant with the same ability to activate EC. This was mainly attributed to the 
presence of HBP. Further, we provide evidence for a pivotal role of the kallikrein-
kinin system in the paracrine signaling pathway that links PMN recruitment with 
derangement of the endothelial barrier in inflammatory reactions. Originally, this 
cascade was shown to be initiated during contact of blood with negatively charged 
artificial surfaces (Colman & Schmaier, 1997). Although similar activation may occur 
in contact of blood with subendothelial collagens or bacterial membranes in vivo, a 
physiologic mechanism for triggering the kallikrein-kinin cascade has remained 
elusive. Our present findings suggest that PMN activation and adhesion to the 
endothelial lining constitutes a physiologic basis for intravascular kinin formation. 
However, the activation pathway remains unknown and there are several possible 
mechanisms for neutrophil-induced HK breakdown. 
Figure 6. PMN-induced plasma leakage in vivo is attenuated following inhibition of plasma 
kallikrein. A) Representative in vivo micrographs showing plasma leakage in the hamster cheek pouch
before (Pre-stim), 10 min after topical LTB4 stimulation (LTB4), following a 15 min wash period 
(Recovery), and after bradykinin stimulation (Bradykinin). Images were taken during control
conditions (Control, n=3), following treatment with B1 and B2 receptor antagonists (n=3) or a PK
inhibitor (n=3). Scale bar, 500 µm. B) Adherent cells following LTB4 treatment. Values are mean ± 
SD. 
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Heparan sulfate and related glycosaminoglycans have been suggested to anchor HK 
on endothelial cells (Renne et al., 2000; Schmaier, 2008), and it appears that HK is 
protected from proteolytic processing while it is bound to the cell surface 
glycosaminoglycans (Renne et al., 2005). This inhibitory shield can be overcome by 
competitive displacement of HK (Renne et al., 2005). Possibly, PMN granule 
proteins, e.g. HBP, stimulate displacement of HK from the EC surface because of 
charge interactions. HBP carries a large number of positively charged amino acid 
residues concentrated to one side of the protein (Iversen et al., 1997), creating a 
strong basic patch that favors binding to negatively charged proteoglycans. Therefore, 
the mechanism behind PMN granule protein activation could be an interference with 
HK binding to EC thus allowing for proteolytic cleavage into active kinin fragments. 
A charge-dependent interaction is consistent with the capacity of anionic compounds 
to inhibit increases in permeability caused by activated neutrophils (Rosengren et al., 
1989; Gautam et al., 2000). 
An alternative pathway for activation of the kallikrein-kinin system by PMN may be 
related to the proteolytic activity of PMN granule proteins, as has been suggested 
previously (Stuardo et al., 2004). Specifically neutrophil elastase and proteinase 3, 
which are located in the primary granules (Borregaard et al., 2007), have been shown 
to cause kininogen hydrolysis (Imamura et al., 2002; Kahn et al., 2009). However, of 
principal physiological relevance is the fact that HBP, in addition to being stored in 
the primary granules, is discharged from secretory vesicles in close proximity to the 
neutrophil plasma membrane (Tapper et al., 2002). While elastase and related 
neutrophil-derived proteases are only slowly mobilized from the primary and 
secondary granules, storage of HBP in secretory vesicles allows for its instantaneous 
release upon cell activation and adhesion to the endothelial lining, which fits with the 
kinetics of neutrophil-evoked alterations in EC barrier function (Gautam et al., 1998). 
Previous data have shown that activated neutrophils trigger intracellular Ca2+ 
mobilization, remodeling of the actin cytoskeleton and increased paracellular 
permeability in cultured EC largely identical to the responses achieved by directly-
acting agonists such as bradykinin (Lindbom, 2003), which is generated by activation 
of the kallikrein-kinin system (Schmaier, 2008). The similarity in the EC responses to 
activated PMN and direct agonist stimulation is explained by our findings as we show 
that these two, previously not linked, pathways converge at the endothelial cell 
surface through the generation of bradykinin. 
 
Neutrophil recruitment and increased vascular permeability are related 
but dissociated events (paper II and III) 
The close connection between neutrophil recruitment and plasma extravasation, which 
has been shown in several studies (Wedmore & Williams, 1981; Arfors et al., 1987) 
makes it reasonable to hypothesize that plasma leaks from the blood stream as the 
neutrophil migrates across the endothelium. However, we show that neutrophil 
recruitment and plasma extravasation can be dissociated events. The mouse pleurisy 
model allows for simultaneous assessment of leukocyte accumulation and exudate 
formation and this model was used in Lam4-/- mice as well as WT mice that had been 
treated with inhibitors to the kallikrein-kinin system. When pleurisy is induced by 
thioglycollate, the edema formation is neutrophil-dependent. It was found that mice 
deficient in the laminin α4 chain exhibited a decrease in PMN recruitment but had a 
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normal exudate formation compared to WT mice (Figure 2D and 7A respectively). On 
the contrary, WT mice treated with inhibitors of the kallikrein-kinin system had 
attenuated plasma extravasation but there was no effect on neutrophil extravasation 
(Figure 5C and 7B respectively).  
Few studies have attempted to investigate a dissociation between neutrophil 
recruitment and vascular permeability using inhibitors or genetically modified mice. 
However, Zeng et al. reported that leukocyte adhesion and emigration not always 
cause a corresponding increase in vascular permeability and conclude that the 
mechanisms that regulate leukocyte recruitment must be different from those 
controlling endothelial barrier function (Zeng et al., 2002). Further, inhibition of 
inducible NO synthase attenuates increased vascular permeability without an effect on 
PMN recruitment in a model of acute lung injury induced by intestinal ischemia/ 
reperfusion (Cavriani et al., 2004). Reduced vascular permeability without altered 
adhesion or emigration of leukocytes was also shown in the LTB4 stimulated hamster 
cheek pouch preparation after treatment with dextran sulphate, and the authors 
speculated that dextran sulphate might interfere with neutrophil granule proteins 
(Rosengren et al., 1989).  
Neutrophil granule proteins are released when the cell adheres to the endothelium and 
have been shown to increase vascular permeability (Gautam et al., 2000). In 
accordance, the response seen in Lam4-/- mice suggests that adhesion to the 
endothelium rather than transmigration through the vessel wall is important for 
increased vascular permeability. Another possibility for the dissociation could be the 
adhesive interaction and ligation of EC adhesion molecules that causes EC activation, 
not paracrine signaling via granule proteins. However, this is disputed by the lack of 
effect on adhesion (c.f. Figure 6B) or recruitment in the animals treated with 
inhibitors of the kallikrein-kinin system despite attenuated permeability changes. 
Therefore neutrophil granule proteins released primarily from secretory vesicles 
appears as the most probable mechanism for altered endothelial barrier function. The 
kallikrein-kinin system could serve an essential link between these two events.  
 
 
 
 
Figure 7. Neutrophil accumulation and 
plasma leakage are related, but dissociated 
events. Pleurisy was induced by injection of 
100 μl thioglycollate into the pleural cavity. 
Dashed line represents values for PBS 
treatment. A) Plasma extravasation calculated 
as clearance volume in WT (n=7) and 
Lam4-/- (n=7) mice. B) Neutrophil 
accumulation in mice treated with inhibitors 
to the kallikrein-kinin system (n=5-8). Values 
are mean ± SEM (A) and SD (B). 
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Neutrophils play a role in edema formation and tissue loss following 
traumatic brain injury (paper IV) 
Leukocyte-induced adjustment of endothelial barrier capacity represents an important 
regulatory mechanism in immune surveillance allowing blood components to leave 
the vasculature and enter into extravascular tissue. However, derangement of the 
endothelial barrier due to neutrophil activation may be detrimental and even fatal in 
diverse inflammatory conditions such as infectious and allergic disease, ischemia-
reperfusion, sepsis, and traumatic brain injury. TBI is associated with inflammatory 
responses leading to BBB dysfunction and edema formation, activation of resident 
and recruitment of bloodborne leukocytes and impaired function (Lenzlinger et al., 
2001). Severe TBI continues to be a leading cause of death and morbidity. Systemic 
and intracranial physiologic management, such as fluid resuscitation and intracranial 
pressure monitoring contribute to the greatest impact on survival. However, to 
minimize the secondary injury, pharmacological intervention will be critical in future 
treatments and it is therefore important to understand the mechanisms behind 
secondary injury following TBI. Hence, it was therefore of interest to investigate the 
role of PMN in TBI, specifically in the edema formation.  
Neutrophil recruitment and edema formation are key events following traumatic brain 
injury. However, the connection between the two phenomena is not clear. Increased 
brain water content is an important clinical outcome of TBI as increased intracranial 
pressure may result in impaired blood supply and oxygen delivery to the parenchymal 
tissue (Unterberg et al., 2004). We used two methods to determine edema formation 
following TBI caused by CCI; assessment of brain water content and Evan’s blue 
extravasation. Brain water content has been shown to increase following TBI and 
remain increased for up to 7 days (Hellal et al., 2004). Here, we show that this 
increase 48 hours after injury is attenuated in mice that are depleted of neutrophils 
indicating a role for PMN in the edema formation (Figure 8A). In order to assess 
disruption of the BBB, we used Evan’s blue as a marker for macromolecule 
extravasation four and 24 hours after injury. CCI resulted in an increased EB 
Figure 8. Brain water content, but not macromolecule extravasation, following TBI is affected by neutrophil 
depletion. A) Brain water content in the contralateral and ipsilateral areas 48 hours after CCI in intact (black bars) and PMN-
depleted (open bars) mice. B) Evan’s blue content in the contralateral and ipsilateral areas at 4 hours after CCI in intact
(black bars) and PMN-depleted (open bars) mice. C) Mice were sham or CCI operated and neutrophils were left intact (sham: 
hatched bars, CCI: black bars) or depleted (sham: grey bars, CCI: open bars), and Evan’s blue content was measured 24
hours later in the four different areas of the brain. Area 2 is the injured site. * indicates significant difference at p < 0.05. 
Values are mean ± SD. 
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extravasation in the injured area compared to the contralateral side or sham-operated 
animals at four and 24 hours after injury (Figure 8B and 8C). There was a tendency 
(p=0.081) for an attenuation of EB content on the injured side (area 2) in the PMN-
depleted animals 24 hours but not four hours after CCI. Taken together, these data 
indicate that neutrophils contribute to brain edema but not necessarily through 
disruption of the BBB.  
Our findings here could clarify the inconsistencies in previous research regarding the 
role of PMN in brain edema formation, as the time point for measurement seems to 
affect the results. For example, a previous study which could not confirm a role of 
neutrophils in TBI measured edema formation at four hours after trauma (Whalen et 
al., 1999). We show similar results. Possibly, permeability changes due to the direct 
mechanical insult caused by CCI mask effects of neutrophil activation at early time 
points. Hemoglobin values have been shown to be the highest four hours after injury 
(Hellal et al., 2004) indicating bleeding and large openings in the BBB. Another 
reason for differing results may be that EB extravasation is a measure of 
macromolecular efflux across BBB, whereas fluid can accumulate in brain tissue for 
other reasons without an increase in vascular permeability. The predominant form 
edema responsible for brain swelling and increased intracranial pressure following 
TBI has been shown to be cellular and not vasogenic (Beaumont et al., 2000; 
Marmarou et al., 2006), which may in part explain our results. The role for PMN 
could also be time dependent with PMN being more important at later time points. 
The exact mechanism of how neutrophils may cause edema formation following 
traumatic brain injury is not entirely understood. Possible mechanisms include 
decreased BBB function, increased breakdown of cells leading to cytotoxic edema, 
and the production and release of oxygen radicals and proteases. 
We show that microglial activation is less prominent in mice that are rendered 
neutropenic. In the cortex there was a large number of activated microglia after TBI 
which was significantly reduced in the PMN-depleted group (Figure 9A). In 
neutrophil-depleted mice there was a significant reduction of tissue loss compared to 
intact mice both at 7 and 14 days after injury (Figure 9B,C). Thus, there is a beneficial 
effect of PMN depletion in the later phase of the injury development, possibly due to 
less edema or a reduced number of inflammatory cells. Decreased microglia 
activation and tissue injury as a result of neutrophil depletion might be due to an 
Figure 9. Neutrophil depletion attenuates microglial activation and tissue loss following TBI. A)
Quantification of Mac-2 positive cells. B, C) Tissue loss one (A) and two (B) weeks after TBI in mice
with intact PMN (black bars) and mice that were rendered neutropenic (open bars). * indicates
significant difference at p < 0.05. Values are mean ± SD. 
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attenuation of the secondary injury caused by PMN. Another possibility could be that 
recruited PMN release inflammatory mediators and granule proteins which activate 
microglia and cause damage to the parenchymal cells. It has previously been shown 
that blocking ICAM-1, thus reducing PMN recruitment, results in improved 
neurological scores following brain injury (Knoblach & Faden, 2002). PMN may 
aggravate the injury by several mechanisms; especially their ability to secrete matrix 
metalloproteinases (MMPs), reactive oxygen species and cytokines have been 
implicated in this respect (Nguyen et al., 2007). Inhibiting any of these factors were 
shown to be neuroprotective in in vivo models of TBI (Lewen et al., 2000; Wang et 
al., 2000; Bermpohl et al., 2007), making the assumption that PMN activation and 
infiltration is involved in the secondary injury after TBI highly plausible.  
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CONCLUDING REMARKS 
 
The following conclusions can be drawn based on the experimental evidence 
presented in this thesis: 
1. Lack of laminin-411 in the perivascular basement membrane leads to impaired 
leukocyte migration through the vessel wall indicating that this laminin 
isoform is required for efficient recruitment of leukocytes in inflammation. 
 
2. Leukotriene B4 evokes increased vascular permeability and plasma exudation 
through inducing neutrophil degranulation and release of heparin binding 
protein. 
 
3. Neutrophil-induced increase in vascular permeability involves activation of 
the kallikrein-kinin system and can be inhibited without affecting cell 
recruitment. 
 
4. Neutrophils contribute to edema formation and tissue damage following 
traumatic brain injury. 
 
These findings imply a significant role for neutrophils in inflammatory edema 
formation, which constitutes a significant clinical problem in disease conditions such 
as sepsis, brain trauma and different forms of pulmonary inflammation. Although it 
might be tempting to suggest that inhibition of PMN function in acute inflammatory 
reactions would have beneficial effects overall, this may not be the case. Neutrophils 
are known to cause tissue damage through the release of ROS and proteases, but are 
also absolutely essential in normal host defence. They are equipped with an array of 
antimicrobial proteins and have a phagocytic machinery of fundamental importance in 
clearing microbial infections, and they interact with other leukocytes to regulate and 
adjust the immune response. The ability to separately control neutrophil recruitment 
on the one hand and alteration of vascular permeability caused by the activated 
neutrophils on the other, with for example inhibitors to granule proteins, or the 
kallikrein-kinin system, allows for selective inhibition of edema formation while 
maintaining mobilization of these protective immune cells. 
Both neutrophil-derived HBP and the kallikrein-kinin system have been implicated in 
the acute inflammatory reaction associated with sepsis. As suggested by the findings 
in this thesis, there is a close interaction between these mediators. Using this 
knowledge, future experiments could possibly identify novel targets to decrease the 
severity of sepsis. Further, the  kallikrein‐kinin  system  has  been  implicated  in  the 
mechanism behind edema  formation  following TBI, and especially  inhibition of 
the B2 receptor has been shown to reduce edema formation. Therefore, in light 
of the findings on involvement of the kallikrein‐kinin system in PMN‐dependent 
alterations  in  vascular  permeability,  it  is  of  interest  to  more  thoroughly 
investigate the role of the neutrophil‐kinin axis in TBI. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Inflammation är viktigt för läkning efter infektion eller skada. Vid inflammation 
rekryteras vita blodkroppar från blodet till den skadade vävnaden. De fastnar först på 
de celler som sitter på insidan av blodkärl, endotelceller, i närheten av det infekterade 
eller skadade området och vandrar sedan igenom kärlväggen. Under denna 
rekryteringsprocess kommer de vita blodkropparna skapa ett läckage av vätska och 
proteiner ut från blodet vilket leder till svullnad. En svullnad kan hindra det dagliga 
livet om den uppstår vid till exempel en knä- eller fotled, men kan vara livshotande 
vid. Experimenten i den här avhandlingen var utformade för att försöka förstå hur de 
vita blodkropparna tar sig från blodet ut till ett sår eller en skada, och varför en 
svullnad uppstår samtidigt.  
För att likna inflammationsprocessen användes vita blodkroppar och endotelceller 
från människa, samt modeller i möss. Resultat från experimenten visade att de vita 
blodkropparna behöver känna igen ett protein kallat Laminin-411 för att kunna ta sig 
igenom kärlväggen. Detta protein sitter under endotelcellerna och hjälper blodkärlet 
att få rätt form. Möss utan Laminin-411 visar en minskad rekrytering av vita 
blodkroppar, d.v.s. färre celler tar sig från blodet till en skada eller infektion. LTB4 är 
en substans som släpps ut från celler vid en infektion och drar vita blodkroppar till sig. 
Mänskliga vita blodkroppar som inkuberades med LTB4 släppte ut ett ämne kallat 
HBP. HBP kan i sin tur göra så att det läcker ut vätska och protein från blodet vilket 
leder till svullnad. Vidare visades att svullnaden som uppstår när de vita 
blodkropparna tar sig från blodet är beroende av bradykinin som är ett ämne som 
frisätts vid inflammation. I möss som behandlades mot bradykinin kunde de vita 
blodkropparna ta sig ut från blodet utan att det bildades en svullnad. Eftersom de vita 
blodkropparna behövs för läkning så kan det vara önskvärt att stoppa svullnaden utan 
att minska antalet vita blodkroppar som lämnar blodet. Slutligen testades rollen för de 
vita blodkropparna i möss som utsattes för traumatisk hjärnskada. Möss som 
behandlades så att vita blodkroppar saknades i blodet fick mindre svullnad i hjärnan 
och även en minskad skada.  
För att kunna motverka svullnad vid inflammation är det viktigt att förstå hur den 
uppkommer. Resultaten i den här avhandlingen kan förhoppningsvis bidra till att 
utveckla läkemedel som kan användas vid inflammation för att förbättra prognosen 
för patienter med sjukdomstillstånd som ger svullnad i hjärnan eller lungorna.  
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LIST OF ABBREVIATIONS  
 
AJ Adherens junction 
BBB Blood-brain barrier 
BM Basement membrane 
C5a Complement factor 5a 
[Ca2+]i Intracellular Calcium concentration 
CCI Controlled cortical impact 
CMK H-D-Pro-Phe-Arg-chloromethylketone 
CNS Central nervous system 
DTH Delayed time hypersensitivity 
DNFB 1-Fluoro-2,4-dinitrobenzene 
EC Endothelial cell 
ESAM Endothelial cell selective adhesion molecule 
FITC Fluorescein isothiocyanate 
fMLP Formyl-Methionyl-Leucyl-Phenylalanine 
FPRL1 Formyl Peptide Receptor Like-1 
FPR1 Formyl Peptide Receptor 1 
FXII Factor XII 
GPCR G protein coupled receptor 
HBP Heparin binding protein 
HK High molecular weight kininogen 
HUVEC Human umbilical vein endothelial cells 
ICAM-1 Intercellular adhesion molecule-1 
IL Interleukin 
IVM Intravital microscopy 
JAM Junctional adhesion molecule 
LK Low molecular weight kininogen 
LT Leukotriene 
LTB4 Leukotriene B4 
MCP-1 Monocyte chemotactic protein-1 
MMP Matrix metalloprotease 
MPO Myeloperoxidase 
MLC Myosin light chain 
MLCK Myosin light chain kinase 
MLCP Myosin light chain phosphatase 
NO Nitric oxide 
p120 p120 catenin 
PAF Platelet activating factor 
PAR Proteinase activated receptors 
PECAM-1 Platelet/ endothelial cell adhesion molecule-1 
PGE2 Prostaglandin E2 
PI3K 1-phosphatidylinositol 3-kinase 
PK Plasma kallikrein 
PKC Protein kinase C 
PMN Polymorphonuclear leukocyte 
ROCK RhoA kinase 
ROS Reactive oxygen species 
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SNARE Soluble NSF attachment receptor 
TBI Traumatic brain injury 
TJ Tight junction 
TNF Tumor necrosis factor 
VCAM-1 Vascular cell adhesion molecule-1 
VE-cadherin Vascular endothelial-cadherin 
VE-PTP Vascular endothelial protein tyrosine phosphatase 
VEGF Vascular endothelial growth factor 
ZO Zonula occludens 
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